all report title image
  • Published On : Aug 2022
  • Code : CMI5182
  • Industry : Pharmaceutical
  • Pages : 176
  • Formats :

The most common areas of the body where acne appears on the skin are the face, forehead, chest, shoulders, and upper back. Genetics, fluctuating hormone levels, stress, high humidity, and the use of greasy or oily personal care products are a few of the factors. Teenagers are frequently affected by acne, but it can affect anyone.

Global acne medication market is estimated to be valued at US$ 7,594.3 million in 2022 and is expected to exhibit a CAGR of 4.5% during the forecast period (2022-2030).

Figure 1. Global Acne Medication Market Share (%), by Type, 2022

Acne Medication  | Coherent Market Insights

Global Acne Medication Market- Drivers

Increasing robust pipeline of acne medications in market are expected to drive market growth over the forecast period. For instance, in April 2021, Bausch Health Companies Inc., a global healthcare company, and Ortho Dermatologics, one of the major prescription dermatological health care companies, announced statistically significant topline results from a second pivotal Phase 3 clinical trial assessing IDP-126, a combination retinoid, anti-bacterial, and antibiotic topical, to treat acne vulgaris in patients nine years of age and older. If approved, IDP-126 would be the first of its kind to use this triple combination.

Increasing prevalence of acne related disorders is expected to drive market growth over the forecast period. For instance, according to the data provided by the American Academy of Dermatology Association in 2021, acne is the most common skin condition in the U.S. that affects approximately 50 million people annually in the country. Moreover, approximately 85% of people between the ages of 12 and 24 experience at least minor acne.

CMI table icon

Acne Medication Market Report Coverage

Report Coverage Details
Base Year: 2021 Market Size in 2022: US$ 7,594.3 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2022 to 2030
Forecast Period 2022 to 2030 CAGR: 4.5% 2030 Value Projection: US$ 10,839.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Drug Class: Retinoid (Topical Retinoid, Oral Retinoid), Antibiotics (Topical Antibiotics, Oral Antibiotics), Fixed Dose Combinations (Clindamycin + Benzoyl Peroxide, Clindamycin + Tretinoin, Adapalene + Benzoyl Peroxide, Tretinoin + Benzoyl Peroxide, Others), Salicylic Acid, Azelaic Acid, Benzoyl Peroxide, Others
  • By Type: Prescription, OTC
  • By Indication: Inflammatory Acne, Non-Inflammatory Acne
  • By Formulation: Topical Medication, Oral Medication
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Companies covered:

Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd

Growth Drivers:
  • Increasing prevalence of acne related disorders
  • Robust pipeline of acne medications
Restraints & Challenges:
  • Side effects associated with acne medications
  • Rising use of alternative treatments

Figure 2. Global Acne Medication Market Share (%), by Region, 2022

Acne Medication  | Coherent Market Insights

Global Acne Medication Market– Impact of Coronavirus (COVID-19) Pandemic

The coronavirus or COVID-19 outbreak started from Wuhan, China in 2019 and has spread across all the continents of the world, affecting various industries globally. Economy in countries all over the world such as India, Italy, Bangladesh, Sri Lanka, the U.S., Morocco, and others has been disrupted due to lockdowns implemented by governments to combat spread of coronavirus since 2020. The COVID-19 pandemic had a negative economic impact on the global acne medication market, owing to the interruption in the visits to hospitals due to lockdown. For instance, according to a cross-sectional questionnaire-based study published by ScienceDirect, in December 2020, a study was conducted at the dermatology clinics at King Abdullah University Hospital (KAUH), Jordan University of science and Technology, Irbid, Jordan, to study the impact of COVID-19 pandemic on the continuity of care for dermatologic patients on systemic therapy during the period of strict lockdown (march 2020 till first week of June 2020). The study included patients on regular systemic medications (e.g Methotrexate, cyclosporine, oral retinoids and others) who were being followed in the outpatient dermatology. According to the study, 80.5% were unable to come to hospital during lockdown as no out-patient clinics were available during that period. However, most patients (79.2%) in jordan were able to continue their systemic treatment during the lockdown period.

Global Acne Medication Market: Key Developments

In March 2021, Fortress Biotech, Inc., a biopharmaceutical company, announced a partnership with Journey Medical Corporation, a commercial-stage pharmaceutical company, to launch an oral isotretinoin under the brand name Accutane (isotretinoin capsules USP) in the U.S. Accutane is an oral medication that is indicated for the treatment of severe recalcitrant nodular acne.

In March 2021, Galderma Laboratories, L.P., a Switzerland-based pharmaceutical company, celebrated Retinoid Education Week for the fourth time. The purpose of Retinoid Education Week is to inform more than 50 million Americans who suffer from acne about the effectiveness of retinoids, which helps in acne treatment

Global Acne Medication Market: Restraint

The major factors that hinder growth of the global acne medication market include high side effects associated with acne medications and rising use of alternative treatments. The side effects of acne medications are determined by the type and strength of the treatment. For instance, skin dryness and irritation are the most frequent adverse reactions to topical acne treatments. Although, the effects of oral and topical drugs can vary, they might also have some similar adverse effects. Some of serious side effects of acne medication includes skin rash or hives, swelling of the face, lips, or tongue, severe burning or swelling of a treated area, throat tightness, shortness of breath or difficulty breathing.

Global Acne Medication Market- Key Players

Major players operating in the global acne medication market include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It results in pimples, blackheads, or whiteheads. Although, it can afflict anyone at any age, acne is most prevalent in teenagers. The lumps and pimples heal slowly, and just as one starts to go, another one seems to appear. Depending on how severe it is, acne can leave skin scars and create emotional distress. Acne treatments function by lowering sebum production, curing bacterial infections, and/or reducing swelling. Sebum produced by the sebaceous glands in healthy skin is released onto the skin's surface through the pore, a follicular opening. The follicle is lined with keratinocytes, a kind of skin cell. The keratinocytes normally ascend to the skin's surface during skin cell shedding. Hair, sebum, and keratinocytes clump together in the pore of an acne patient. As a result, the keratinocytes are kept from shedding and sebum is kept from penetrating the skin's surface. Inflammation, including swelling, redness, heat, and pain, is brought on by bacteria that ordinarily reside on the skin and can proliferate in clogged follicles when oil and cells are present.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as product is expected to drive market growth over the forecast period. For instance, in March 2022, Galderma, a pharmaceutical company, announced the U.S. launch of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3%, during the American Academy of Dermatology (AAD) Annual Meeting, held during March 25-29, 2022, in Boston, Massachusetts. The first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 formulation that has been shown to effectively treat moderate to severe face acne is TWYNEO Cream.

Key features of the study:

  • This report provides an in-depth analysis of the global acne medication market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global acne medication market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global acne medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne medication market

Detailed Segmentation:

  • Global Acne Medication Market, By Drug Class:
    • Topical Retinoid
    • Oral Retinoid
    • Topical Antibiotics
    • Oral Antibiotics
    • Clindamycin + Benzoyl Peroxide
    • Clindamycin + Tretinoin
    • Adapalene + Benzoyl Peroxide
    • Tretinoin + Benzoyl Peroxide
    • Others
    • Retinoid
    • Antibiotics
    • Fixed Dose Combinations
    • Salicylic Acid
    • Azelaic Acid
    • Benzoyl Peroxide
    • Others
  • Global Acne Medication Market, By Type:
    • Prescription
    • OTC
  • Global Acne Medication Market, By Indication:
    • Inflammatory Acne
    • Non-Inflammatory Acne
  • Global Acne Medication Market, By Formulation:
    • Topical Medication
    • Oral Medication
  • Global Acne Medication Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Acne Medication Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Galderma Laboratories, L.P.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Reckitt Benckiser Group PLC.
    • Bausch Health Companies Inc.
    • GlaxoSmithKline plc.
    • Arctic Therapeutics International
    • Mylan N.V.
    • Sun Pharmaceutical Industries Ltd.
    • AbbVie Inc.
    • Biopharmx, Inc.
    • Paratek Pharmaceuticals, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • F.Hoffmann-La Roche Ltd

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

Global acne medication market size is estimated to be valued at US$ 7,594.3 million in 2022 and is expected to exhibit a CAGR of 4.5% between 2022 and 2030.
Factors such as increasing prevalence of acne related disorders and robust pipeline of acne medications are expected to drive the market.
Topical Medication is the leading formulation segment in the market.
The major factors hampering growth of the market includes side effects associated with acne medications and rising use of alternative treatments.
Major players operating in the market include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo